Preatrophy: covert sign of thinned skin

J Am Acad Dermatol. 1989 May;20(5 Pt 1):731-5. doi: 10.1016/s0190-9622(89)70082-7.

Abstract

Overt iatrogenic cutaneous atrophy is easily recognized; however, the earliest signs of such an adverse event may be covert. Preatrophy is proposed as a term to describe the subtle unmasking or normally covert subpapillary vascular channels found by the use of enhanced skin surface magnification techniques. We conducted a randomized double-blind, bilaterally paired comparison clinical trial in patients with chronic plaque psoriasis treated with twice-daily (nonoccluded) superpotent topical steroids for 2 weeks. Occult reversible delicate networks of horizontally oriented vascular channels were found within and surrounding 20% (23/118) of the involved psoriatic plaques during the course of the study. The use of a hand-held magnifying lens (8X), mineral oil, a coverglass, and adequate illumination allow recognition of preatrophy. Preatrophy was more frequently found in women than in men.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Atrophy / chemically induced
  • Betamethasone / adverse effects
  • Betamethasone / analogs & derivatives*
  • Clinical Trials as Topic
  • Clobetasol / adverse effects
  • Clobetasol / analogs & derivatives*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Ointments
  • Prospective Studies
  • Psoriasis / drug therapy*
  • Random Allocation
  • Skin / blood supply
  • Skin / pathology*

Substances

  • Ointments
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Clobetasol